Johnson & Johnson MedTech is showcasing its latest advancements in digital orthopaedics at the American Academy of Orthopaedic Surgeons 2025 Annual Meeting. Building on last year’s momentum of 18 FDA 510(k) clearances and 45 global product launches, the company is unveiling innovations in joint reconstruction, trauma, spine, and surgical robotics.

Key highlights include:

- VELYS robotic-assisted solution, a CT-free system that enhances total knee replacements, now approved for unicompartmental knee arthroplasty.
- KINCISE 2 surgical automated system, designed to reduce the physical strain on surgeons during hip and knee procedures.
- VELYS active robotic assistance for spine, a next-generation platform integrating navigation with active robotics for complex spinal surgeries.
- VOLT trauma system, an advanced plating system for fracture stabilization, now expanding into select European markets.
- INHANCE INTACT shoulder replacement, an FDA-cleared solution enabling patients to move their shoulders immediately post-surgery.
- AI-powered advance case management, optimizing surgery preparation and efficiency for outpatient centers.

These innovations aim to improve precision, efficiency, and patient outcomes while reducing surgical burdens. Johnson & Johnson MedTech continues to leverage digital technology to transform orthopaedic care.